United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use.

Autor: Habib AA; University of California, Irvine, CA, USA., Klink AJ; Cardinal Health, Dublin, OH, USA., Muppidi S; Stanford Neuroscience Health Center, Palo Alto, CA, USA., Parthan A; Alexion, AstraZeneca Rare Disease, Boston, MA, USA.; FibroGen Inc., San Francisco, CA, USA., Sader SC; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Balanean A; Cardinal Health, Dublin, OH, USA., Gajra A; Cardinal Health, Dublin, OH, USA.; Hematology-Oncology Associates of CNY, East Syracuse, NY, USA., Nowak RJ; Yale University School of Medicine, New Haven, CT, USA., Howard JF Jr; Department of Neurology, The University of North Carolina, Chapel Hill, NC, USA. howardj@neurology.unc.edu.

Publikováno v: Journal of neurology [J Neurol] 2024 Sep; Vol. 271 (9), pp. 6114-6126. Date of Electronic Publication: 2024 Jul 25.